Viewing Study NCT00585195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:21 PM
Ignite Modification Date: 2026-02-11 @ 6:35 PM
Study NCT ID: NCT00585195
Status: COMPLETED
Last Update Posted: 2023-02-08
First Post: 2007-12-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer ALK-positive View
None Non-Small Cell Lung Cancer c-Met Dependent View
None Non-Small Cell Lung Cancer ROS Marker Positive View
None Systemic Anaplastic Large-Cell Lymphoma View
None Advanced Malignancies Except Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Crizotinib View
None dose-finding View
None drug-drug interaction View
None ALK rearrangements View
None c-Met mutations or amplifications View
None c-Met dependent tumors View
None ROS1 rearrangements View
None c-Met exon 14 deletion View
None c-Met exon 14 skipping View
None c-Met exon 14 alterations View